Midday trading sees notable shifts with stocks like Novo Nordisk and Qorvo making headlines for various reasons
Meanwhile, Novo Nordisk isn’t having the best day. Their shares dropped 5% after their diabetes drug ingredient got listed for Medicare price negotiations. On the flip side, Qorvo’s stock shot up over 12% after an activist investor revealed a significant stake in the company, pushing for changes to boost its share price.
Vistra, the energy company, faced a setback with a 1.9% drop after a fire at its battery-storage facility in Northern California forced nearby residents to evacuate. In better news, MoonLake Immunotherapeutics gained 4% after Goldman Sachs upgraded it to a buy, highlighting its promising treatment for a skin condition.
Lam Research and Applied Materials also saw gains after an upgrade from KeyBanc, thanks to their ties to AI devices. However, J.B. Hunt fell 6% after missing earnings expectations, reporting lower revenue across its business segments. Fastenal managed a slight increase of 1%, despite missing fourth-quarter targets.
Life360, the location-sharing app, rallied 8% after an upgrade from UBS, while Intel’s shares popped 8% amid takeover rumors following its CEO’s departure. It’s been a mixed bag for stocks today, with some rising and others taking a hit.